{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:58:13Z","timestamp":1790701093678,"version":"4.1.0"},"reference-count":150,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jac\/dkx151","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T19:10:18Z","timestamp":1495653018000},"page":"2156-2170","source":"Crossref","is-referenced-by-count":82,"title":["Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors"],"prefix":"10.1093","volume":"72","author":[{"given":"A. E. J.","family":"Yssel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vanderleyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Steenackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"key\n\t\t\t\t20171012205916_dkx151-B1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.arcmed.2005.06.009","article-title":"Resistance to antibiotics: are we in the post-antibiotic era?","volume":"36","year":"2005","journal-title":"Arch Med Res"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B2","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/j.1462-2920.2009.01972.x","article-title":"The role of antibiotics and antibiotic resistance in nature","volume":"11","year":"2009","journal-title":"Environ Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B3","first-page":"134.","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future","volume":"1","year":"2010","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jsps.2015.01.001","article-title":"Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist","volume":"23","year":"2015","journal-title":"Saudi Pharm J"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B6","first-page":"1","article-title":"Outcome of infections due to pandrug-resistant (PDR) gram-negative bacteria","volume":"5","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B7","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/AAC.01103-16","article-title":"Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the USA","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B8","year":"2014"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B9","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","article-title":"Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections","volume":"21","year":"2015","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B10","first-page":"282.","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections","volume":"6","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B11","first-page":"1157","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00253-010-2468-8","article-title":"Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal","volume":"86","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2003.07.001","article-title":"Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases","volume":"100","year":"2003","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B14","doi-asserted-by":"crossref","first-page":"e37724.","DOI":"10.1371\/journal.pone.0037724","article-title":"Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B16","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/onc.2008.316","article-title":"Nucleoside analogs: molecular mechanisms signaling cell death","volume":"27","year":"2008","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B17","article-title":"Principles and concepts of DNA replication in bacteria and eukarya","volume":"5","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrmicro2688","article-title":"The myriad roles of cyclic AMP in microbial pathogens: from signal to sword","volume":"10","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1462-2920.2009.02032.x","article-title":"Cyclic di-GMP signalling controls virulence properties of Salmonella enterica serovar Typhimurium at the mucosal lining","volume":"12","year":"2010","journal-title":"Environ Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2958.2005.04697.x","article-title":"di-GMP: the dawning of a novel bacterial signaling system","volume":"57","year":"2005","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B21","doi-asserted-by":"crossref","first-page":"e31252.","DOI":"10.1371\/journal.pone.0031252","article-title":"The pyrimidine nucleotide biosynthetic pathway modulates production of biofilm determinants in Escherichia coli","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00253-009-1860-8","article-title":"5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compound","volume":"82","year":"2009","journal-title":"Appl Microbiol Biotechnol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B23","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1007\/s00253-013-4875-0","article-title":"The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability","volume":"97","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jac\/dkm240","article-title":"Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner","volume":"60","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B25","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/314749","article-title":"Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients","volume":"179","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkp339","article-title":"Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis","volume":"64","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2012.01.019","article-title":"Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin","volume":"39","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000057665","article-title":"Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli","volume":"48","year":"2002","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.20546\/ijcmas.2016.505.005","article-title":"Assessment of biological activities of caffeine","volume":"5","year":"2016","journal-title":"Int J Curr Microbiol App Sci"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B30","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1073\/pnas.1504076112","article-title":"Socially mediated induction and suppression of antibiosis during bacterial coexistence","volume":"112","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mib.2008.02.006","article-title":"Antibiotics as signals that trigger specific bacterial responses","volume":"11","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B32","first-page":"20.","article-title":"Concentration-dependent activity of antibiotics in natural environments","volume":"4","year":"2013","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B33","doi-asserted-by":"crossref","first-page":"19484","DOI":"10.1073\/pnas.0608949103","article-title":"Antibiotics as intermicrobial signaling agents instead of weapons","volume":"103","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B34","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1021\/cr2000509","article-title":"Antibiotics as signal molecules","volume":"111","year":"2011","journal-title":"Chem Rev"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10295-006-0112-5","article-title":"Are antibiotics naturally antibiotics?","volume":"33","year":"2006","journal-title":"J Ind Microbiol Biotechnol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1126\/science.1159483","article-title":"Antibiotics and antibiotic resistance genes in natural environments","volume":"321","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drup.2004.02.003","article-title":"Evolution of the serine \u03b2-lactamases: past, present and future","volume":"7","year":"2004","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B38","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1128\/AAC.49.7.2778-2784.2005","article-title":"Structure-based phylogeny of the metallo-\u03b2-lactamases","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B39","first-page":"172","article-title":"Molecular characterization of TEM-type \u03b2-lactamases identified in cold-seep sediments of Edison seamount (south of Lihir Island, Papua New Guinea)","volume":"43","year":"2005","journal-title":"J Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B40","first-page":"243","article-title":"Functional metagenomics reveals diverse \u03b2-lactamases in a remote Alaskan soil","volume":"3","year":"2008","journal-title":"ISME J"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B41","doi-asserted-by":"crossref","first-page":"20140087.","DOI":"10.1098\/rstb.2014.0087","article-title":"The human gut resistome","volume":"370","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B42","first-page":"173.","article-title":"Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer","volume":"7","year":"2016","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B43","first-page":"93","volume-title":"Horizontal Gene Transfer in Microorganisms","year":"2012"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B44","first-page":"520.","article-title":"Role and prevalence of antibiosis and the related resistance genes in the environment","volume":"5","year":"2014","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B45","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/AAC.44.9.2233-2241.2000","article-title":"Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria","volume":"44","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3201\/eid0804.010312","article-title":"Antimicrobial use and antimicrobial resistance: a population perspective","volume":"8","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1476-5381.2011.01643.x","article-title":"Enhancing the utility of existing antibiotics by targeting bacterial behaviour?","volume":"165","year":"2012","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B50","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1073\/pnas.1222706110","article-title":"Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","article-title":"The biology and future prospects of antivirulence therapies","volume":"6","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: a new paradigm for antimicrobial therapy","volume":"3","year":"2007","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1751-7915.2008.00060.x","article-title":"Uracil influences quorum sensing and biofilm formation in Pseudomonas aeruginosa and fluorouracil is an antagonist","volume":"2","year":"2009","journal-title":"Microb Biotechnol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.mi.41.100187.002251","article-title":"Bacterial biofilms in nature and disease","volume":"41","year":"1987","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B56","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.27.4.619","article-title":"Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material","volume":"27","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B58","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B59","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1099\/00221287-143-7-2407","article-title":"The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus","volume":"143","year":"1997","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B60","doi-asserted-by":"crossref","first-page":"10710.","DOI":"10.1038\/ncomms10710","article-title":"Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway","volume":"7","year":"2016","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2174\/138945012803530251","article-title":"Resolving biofilm infections: current therapy and drug discovery strategies","volume":"13","year":"2012","journal-title":"Curr Drug Targets"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrd4000","article-title":"Applying insights from biofilm biology to drug development\u2014can a new approach be developed?","volume":"12","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.coph.2013.07.004","article-title":"Biologically-inspired strategies for combating bacterial biofilms","volume":"13","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2014.65","article-title":"Strategies for combating bacterial biofilm infections","volume":"7","year":"2015","journal-title":"Int J Oral Sci"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B65","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B66","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1128\/AEM.01262-08","article-title":"Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium","volume":"74","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B67","article-title":"How biofilms evade host defenses","volume":"3","year":"2015","journal-title":"Microbiol Spectr"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B68","first-page":"17.","article-title":"Host defence against bacterial biofilms: \u201cMission Impossible\u201d","volume-title":"ISRN Immunology","year":"2012"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800262-9.00001-9","article-title":"Chapter one\u2014Pseudomonas aeruginosa biofilms: mechanisms of immune evasion","volume":"86","year":"2014","journal-title":"Adv Appl Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B70","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00081-07","article-title":"Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B71","author":"Antibiotic resistance threats in the USA. Center for Disease Control and Prevention","year":"2013"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/2006\/707296","article-title":"Where have all the antibiotics gone?","volume":"17","year":"2006","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is big pharma getting out of antibacterial drug discovery?","volume":"6","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B74","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B75","doi-asserted-by":"crossref","first-page":"11596.","DOI":"10.1038\/srep11596","article-title":"Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections","volume":"5","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B76","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/cr900028p","article-title":"Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer","volume":"109","year":"2009","journal-title":"Chem Rev"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B77","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/381678","article-title":"The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities","volume":"38","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B78","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/496981","article-title":"The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","year":"1957","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B80","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B81","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000238445","article-title":"Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin, and netilmicin","volume":"32","year":"1986","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/AAC.23.3.374","article-title":"Interactions of \u03b2-lactam antibiotics and antineoplastic agents","volume":"23","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.chembiol.2014.11.006","article-title":"The complex mechanism of antimycobacterial action of 5-fluorouracil","volume":"22","year":"2015","journal-title":"Chem Biol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/bi00910a001","article-title":"The mechanism of an osmotic instability induced in E. coli K-12 by 5-fluorouracil","volume":"1","year":"1962","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B85","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0021-9258(18)96184-3","article-title":"On the initial stage in peptidoglycan synthesis: effect of 5-fluorouracil substitution on phospho-N-acetylmuramyl-pentapeptide translocase (uridine 5\u2032-phosphate)","volume":"242","year":"1967","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B86","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1042\/bj0770448","article-title":"5-Fluorouracil and mucopeptide biosynthesis by Staphylococcus aureus","volume":"77","year":"1960","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1099\/00222615-37-1-62","article-title":"Radiochemical assay to measure the biofilm produced by coagulase-negative staphylococci on solid surfaces and its use to quantitate the effects of various antibacterial compounds on the formation of the biofilm","volume":"37","year":"1992","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12088-011-0142-1","article-title":"Indole affects biofilm formation in bacteria","volume":"50","year":"2010","journal-title":"Indian J Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jmb.2007.07.037","article-title":"Structure and function of the E. coli protein YmgB: a protein critical for biofilm formation and acid-resistance","volume":"373","year":"2007","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B90","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/CCM.0b013e3181f265ba","article-title":"Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine\/silver sulfadiazine in preventing catheter colonization","volume":"38","year":"2010","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B91","doi-asserted-by":"crossref","first-page":"547.","DOI":"10.1136\/bmj.1.6112.547","article-title":"Fluorouracil cardiotoxicity","volume":"1","year":"1978","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B93","first-page":"566","article-title":"Chemotherapeutic activity of 5-fluorocysteine","volume":"161","year":"1963","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B94","author":"Drugs.com","year":"2017"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-85-2-237","article-title":"5-Azacytidine, a new anticancer drug with effectiveness in acute myelogenous leukemia","volume":"85","year":"1976","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B96","first-page":"959","article-title":"Biochemistry of azacytidine: a review","volume":"71","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B97","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-0458","article-title":"Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines","volume":"69","year":"2009","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B98","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01406-09","article-title":"5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1","volume":"83","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B99","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4161\/cbt.3.11.1308","article-title":"Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy","volume":"3","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B100","doi-asserted-by":"crossref","first-page":"e14060.","DOI":"10.1371\/journal.pone.0014060","article-title":"Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B101","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1128\/IAI.05186-11","article-title":"The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39","volume":"79","year":"2011","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.micpath.2012.08.003","article-title":"Effect of 5-azacytidine on in vitro biofilm formation of Streptococcus pneumoniae","volume":"53","year":"2012","journal-title":"Microb Pathog"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12866-016-0741-4","article-title":"5-Azacytidine induces transcriptome changes in Escherichia coli via DNA methylation-dependent and DNA methylation-independent mechanisms","volume":"16","year":"2016","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B104","doi-asserted-by":"crossref","first-page":"e0139238","DOI":"10.1371\/journal.pone.0139238","article-title":"The small molecule DAM inhibitor, pyrimidinedione, disrupts Streptococcus pneumoniae biofilm growth in vitro","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B105","first-page":"1","article-title":"Sinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits Streptococcus pneumoniae biofilm growth","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2016.02.015","article-title":"A study of the utility of azathioprine metabolite testing in myasthenia gravis","volume":"293","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"1","key":"key\n\t\t\t\t20171012205916_dkx151-B107","first-page":"CD000478.","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2015.05.025","article-title":"Azathioprine treatment of intractable pruritus: a retrospective review","volume":"73","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B109","doi-asserted-by":"crossref","first-page":"774","DOI":"10.5021\/ad.2015.27.6.774","article-title":"The clinical efficacy of azathioprine in Korean patients with atopic dermatitis","volume":"27","year":"2015","journal-title":"Ann Dermatol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B110","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1111\/j.1572-0241.1999.01532.x","article-title":"Optimum duration of treatment with 6-mercaptopurine for Crohn\u2019s disease","volume":"94","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B111","first-page":"e161","article-title":"On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis","volume":"2","year":"2006","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B112","first-page":"418","article-title":"Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro","volume":"52","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.00043-12","article-title":"Cyclic di-GMP: the first 25\u2009years of a universal bacterial second messenger","volume":"77","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B114","doi-asserted-by":"crossref","first-page":"e28351","DOI":"10.1371\/journal.pone.0028351","article-title":"Complex c-di-GMP signaling networks mediate transition between virulence properties and biofilm formation in Salmonella enterica serovar Typhimurium","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B115","first-page":"262","article-title":"Principles of c-di-GMP signalling in bacteria","volume":"7","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B116","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-3476(99)70180-0","article-title":"Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?","volume":"135","year":"1999","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B117","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000087584","article-title":"Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5\u2009years in the international caffeine for apnea of prematurity (CAP) trial","volume":"88","year":"2005","journal-title":"Neonatology"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B118","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3565(25)20409-8","article-title":"Caffeine and theophylline as adenosine receptor antagonists in humans","volume":"258","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0027-5107(80)90133-5","article-title":"The effect of caffeine on cell growth and metabolism of thymidine in Escherichia coli","volume":"73","year":"1980","journal-title":"Mutat Res"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00433723","article-title":"Caffeine-death in Escherichia coli","volume":"102","year":"1968","journal-title":"Mol Gen Genet"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B121","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JB.96.1.198-204.1968","article-title":"Mechanism of caffeine enhancement of mutations induced by sublethal ultraviolet dosages","volume":"96","year":"1968","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B122","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1073\/pnas.87.9.3522","article-title":"Molecular mechanisms of DNA repair inhibition by caffeine","volume":"87","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B123","first-page":"416","article-title":"Enhancement of ultraviolet-induced mutation in bacteria by caffeine","volume":"92","year":"1961","journal-title":"Z Vererbungslehre"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1574-6968.1986.tb01360.x","article-title":"Cell filamentation in an Escherichia coli K-12 fic mutant caused by theophylline or an adenylate cyclase gene (cya)-containing plasmid","volume":"34","year":"1986","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B125","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3390\/s130405117","article-title":"Caffeine as a potential quorum sensing inhibitor","volume":"13","year":"2013","journal-title":"Sensors (Basel)"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1099\/00222615-33-4-235","article-title":"Mechanisms of zidovudine resistance in bacteria","volume":"33","year":"1990","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/AAC.31.2.274","article-title":"Antibacterial activity and mechanism of action of 3\u2032-azido-3\u2032-deoxythymidine (BW A509U)","volume":"31","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B128","doi-asserted-by":"crossref","first-page":"1249.","DOI":"10.1007\/s10096-011-1220-3","article-title":"Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains","volume":"30","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B129","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"11","year":"1995","journal-title":"Semin Oncol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1631\/jzus.2007.B0307","article-title":"Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer","volume":"8","year":"2007","journal-title":"J Zhejiang Univ Sci B"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B131","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2202","article-title":"Multi-targeting by monotherapeutic antibacterials","volume":"6","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B133","doi-asserted-by":"crossref","first-page":"262ra156.","DOI":"10.1126\/scitranslmed.3009940","article-title":"Prediction of resistance development against drug combinations by collateral responses to component drugs","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B134","first-page":"141","article-title":"Isolation of zidovudine resistant Escherichia coli from AIDS patients","volume":"70","year":"1990","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B135","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1073\/pnas.092016999","article-title":"Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa","volume":"99","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B136","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2310\/JIM.0b013e3182160d70","article-title":"The path from bench to bedside: considerations before starting the journey","volume":"59","year":"2011","journal-title":"J Investig Med"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B137","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?","volume":"163","year":"2011","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B138","first-page":"1047.","article-title":"Streamlining the drug discovery process through repurposing of clinically approved drugs","volume":"2","year":"2015","journal-title":"Austin J Biotechnol Bioeng"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B139","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.2353\/ajpath.2007.060770","article-title":"Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent","volume":"170","year":"2007","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-62703-481-4_14","article-title":"Mouse model of Staphylococcus aureus skin infection","volume":"1031","year":"2013","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B141","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.01330-08","article-title":"Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B142","first-page":"629","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","year":"2016"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B143","author":"FDA","year":"2008"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B144","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/092986711795029555","article-title":"Pyrimidine salvage pathway in Mycobacterium tuberculosis","volume":"18","year":"2011","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B145","first-page":"1","article-title":"Nucleotide metabolism and DNA replication","volume":"2","year":"2014","journal-title":"Microbiol Spectr"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B146","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/JB.141.2.680-686.1980","article-title":"Incorporation and excision of 5-fluorouracil from deoxyribonucleic acid in Escherichia coli","volume":"141","year":"1980","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B147","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B148","first-page":"1","article-title":"Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs","volume":"13","year":"2013","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B149","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3923\/jm.2008.457.465","article-title":"Inhibitory effect of caffeine on growth of various bacterial strains","volume":"3","year":"2008","journal-title":"Res J Microbiol"},{"key":"key\n\t\t\t\t20171012205916_dkx151-B150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/41.2.277","article-title":"Sensitization of Burkholderia cepacia to antibiotics by cationic drugs","volume":"41","year":"1998","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/8\/2156\/18801455\/dkx151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:55:21Z","timestamp":1750276521000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/8\/2156\/3858269\/Repurposing-of-nucleoside-and-nucleobasederivative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":150,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,30]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx151","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,5,30]]}}}